TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients
Maya Dadiani, Daniela Necula, Smadar Kahana‐Edwin, Nino Oren, Tamir Baram, Irina Marin, Dana Morzaev‐Sulzbach, Anya Pavlovski, Nora Balint‐Lahat, Liat Anafi, Stefan Wiemann, Cindy Körner, Einav Nili Gal‐Yam, Camila Avivi, Bella Kaufman, Iris Barshack, Adit Ben‐Baruch
Topics & Concepts
Tumor-infiltrating lymphocytesTriple-negative breast cancerMedicineBreast cancerOncologyInternal medicineCancerImmunotherapyCancer researchCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and Interaction